- Home
- LSB vs ATNM Comparison
LSB vs ATNM Comparison
Compare LSB & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSB
- ATNM
- Stock Information
- Founded
- LSB 2002
- ATNM 2000
- Country
- LSB China
- ATNM United States
- Employees
- LSB N/A
- ATNM N/A
- Industry
- LSB
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- LSB
- ATNM Health Care
- Exchange
- LSB NYSE
- ATNM Nasdaq
- Market Cap
- LSB 49.8M
- ATNM 56.5M
- IPO Year
- LSB N/A
- ATNM N/A
- Fundamental
- Price
- LSB $2.51
- ATNM $1.17
- Analyst Decision
- LSB
- ATNM Strong Buy
- Analyst Count
- LSB 0
- ATNM 4
- Target Price
- LSB N/A
- ATNM $8.75
- AVG Volume (30 Days)
- LSB 15.9K
- ATNM 330.0K
- Earning Date
- LSB 01-21-2025
- ATNM 11-14-2024
- Dividend Yield
- LSB N/A
- ATNM N/A
- EPS Growth
- LSB N/A
- ATNM N/A
- EPS
- LSB N/A
- ATNM N/A
- Revenue
- LSB $79,415,311.00
- ATNM $81,000.00
- Revenue This Year
- LSB $39.33
- ATNM $186.10
- Revenue Next Year
- LSB $75.61
- ATNM $19,248.94
- P/E Ratio
- LSB N/A
- ATNM N/A
- Revenue Growth
- LSB N/A
- ATNM N/A
- 52 Week Low
- LSB $1.88
- ATNM $1.16
- 52 Week High
- LSB $11.20
- ATNM $10.24
- Technical
- Relative Strength Index (RSI)
- LSB 44.96
- ATNM 35.90
- Support Level
- LSB $2.10
- ATNM $1.16
- Resistance Level
- LSB $2.77
- ATNM $1.29
- Average True Range (ATR)
- LSB 0.36
- ATNM 0.09
- MACD
- LSB 0.01
- ATNM 0.00
- Stochastic Oscillator
- LSB 34.68
- ATNM 21.54
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.